Dr. Lowentritt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 N Calvert St
Ste 600
Baltimore, MD 21218Phone+1 410-467-7665Fax+1 410-467-7746
Education & Training
University of MarylandResidency, Urology, 2001 - 2005- University of MarylandResidency, Surgery, 1999 - 2001
Baylor College of MedicineClass of 1999
Certifications & Licensure
MD State Medical License 2005 - 2026
LA State Medical License 2005 - 2012- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 1 citationsImpact of Clinical Factors onF-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study.Benjamin H Lowentritt, Ashesh B Jani, Brian T Helfand, Edward M Uchio, Michael A Morris
Advances in Radiation Oncology. 2024-08-01 - 5 citationsReal-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients With Non-Metastatic Castration-Resistant Prostate Cancer.Benjamin Lowentritt, Gordon Brown, Dominic Pilon, Lorie Ellis, Guillaume Germain
Urology. 2022-08-01 - 35 citationsVARIANTS OF THE EXSTROPHY COMPLEX: A SINGLE INSTITUTION EXPERIENCEBenjamin H. Lowentritt, P. Sean Van Zijl, Dominic Frimberger, Andrew D. Baird, Yegappan Lakshmanan
The Journal of Urology. 2005-05-01
Press Mentions
New ERLEADA® (Apalutamide) Analysis Demonstrates Rapid, Deep Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)February 14th, 2022- (Apalutamide) Oral Presentations Demonstrate Importance of Prostate Specific Antigen (PSA) as Key Efficacy Indicator and Show Strong Patient Adherence RatesSeptember 12th, 2021
The Latest on Prostate Cancer and Bone Health WebinarOctober 31st, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
